Your session is about to expire
← Back to Search
Screening Strategies for Breast Cancer Detection
Study Summary
This trial looked at whether it is better to ask observers to search for simulated masses and calcs separately or together.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You must pass a color vision test called Ishihara.I am over 18 years old.Your vision, even with glasses or contacts, is worse than 20/25.I have a history of muscle or eye disorders.
- Group 1: Mixed Trials
- Group 2: Blocked Trials
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this clinical experiment open to new participants?
"Affirmative. Clinicaltrials.gov's data implies that this clinical trial is currently recruiting patients, with enrollment commencing on September 1st 2022 and the most recent update being done August 2nd 2023. This study requires 70 individuals to be recruited at a single site."
How many participants are being recruited for this trial?
"Affirmative. Evident from the information on clinicaltrials.gov, this scientific trial is actively enrolling patients. This research was first published on September 1st 2022 and has been updated most recently as of August 2nd 2023; 70 participants are required at a single site to complete the study."
Share this study with friends
Copy Link
Messenger